000 | 01184 a2200325 4500 | ||
---|---|---|---|
005 | 20250515082353.0 | ||
264 | 0 | _c20071108 | |
008 | 200711s 0 0 eng d | ||
022 | _a1874-1754 | ||
024 | 7 |
_a10.1016/j.ijcard.2007.05.060 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClancy, Colleen E | |
245 | 0 | 0 |
_aMutation-specific effects of lidocaine in Brugada syndrome. _h[electronic resource] |
260 |
_bInternational journal of cardiology _cOct 2007 |
||
300 |
_a249-52 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
650 | 0 | 4 |
_aBrugada Syndrome _xdrug therapy |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLidocaine _xpharmacology |
650 | 0 | 4 |
_aMuscle Proteins _xgenetics |
650 | 0 | 4 | _aMutation, Missense |
650 | 0 | 4 | _aNAV1.5 Voltage-Gated Sodium Channel |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aSodium Channels _xdrug effects |
700 | 1 | _aWehrens, Xander H T | |
773 | 0 |
_tInternational journal of cardiology _gvol. 121 _gno. 3 _gp. 249-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijcard.2007.05.060 _zAvailable from publisher's website |
999 |
_c17290786 _d17290786 |